Literature DB >> 32145264

Tumor associated macrophages and 'NO'.

Niharika Nath1, Khosrow Kashfi2.   

Abstract

Nitric oxide (NO) and its pro and anti-tumor activities are dual roles that continue to be debated in cancer biology. The cell situations in the tumor and within the tumor microenvironment also have roles involving NO. In early tumorigenic events, macrophages in the tumor microenvironment promote tumor cell death, and later are reprogramed to support the growth of tumor, through regulatory events involving NO and several stimulatory signals. These two opposing and active phenotypes of tumor associated macrophages known as the M1 or anti-tumorigenic state and M2 or pro-tumorigenic state show differences in metabolic pathways such as glycolysis and arginine utilization, signaling pathways and cytokine induction including iNOS expression, therefore contributing to their function. Polarization of M2 to M1 macrophages, inhibition of M2 state, or reprogramming via NO in combination with other signals may determine or alter tumor kinetics. These strategies and an overview are presented.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Macrophages; Nitric oxide; Reprogramming; Tumor microenvironment; iNOS

Year:  2020        PMID: 32145264     DOI: 10.1016/j.bcp.2020.113899

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 2.  The Regulatory Role of α-Ketoglutarate Metabolism in Macrophages.

Authors:  Shaojuan Liu; Jie Yang; Zhenfang Wu
Journal:  Mediators Inflamm       Date:  2021-03-29       Impact factor: 4.711

3.  Production of NOS2 and inflammatory cytokines is reduced by selected protein kinase inhibitors with partial repolarization of HL-60 derived and human blood macrophages.

Authors:  Gábor Bögel; József Murányi; Bálint Szokol; Zoltán Kukor; István Móra; Tamás Kardon; László Őrfi; András Hrabák
Journal:  Heliyon       Date:  2021-12-27

Review 4.  Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression.

Authors:  Andreia Matos; Marcos Carvalho; Manuel Bicho; Ricardo Ribeiro
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

Review 5.  Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO.

Authors:  Khosrow Kashfi; Jasmine Kannikal; Niharika Nath
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

6.  Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy.

Authors:  Hong Wu; Hongyan Li; Yiqiang Liu; Jingchen Liang; Qianshi Liu; Zhigang Xu; Zhongzhu Chen; Xia Zhang; Kun Zhang; Chuan Xu
Journal:  Bioact Mater       Date:  2021-11-03

Review 7.  Natural Compounds as Metabolic Modulators of the Tumor Microenvironment.

Authors:  Ana S Dias; Luisa Helguero; Catarina R Almeida; Iola F Duarte
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

8.  Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells.

Authors:  Yuan Zhuang; Xiaomei Zhao; Baoying Yuan; Zhaochong Zeng; Yixing Chen
Journal:  J Hepatocell Carcinoma       Date:  2021-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.